Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision

AAV vectors are widely used in gene therapy for their strong therapeutic potential

Datroway wins US nod in aggressive breast cancer subtype

Clearance marks major shift beyond chemotherapy

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich

ABDM crosses 100 crore ABHA-linked health records milestone

More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem

OncoSil secures TGA approval for pancreatic cancer device

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy